David Berd
11Patents
6h-index
5Co-inventors
55Inventor score
Filing activity: Dec 4, 1992 → Jun 13, 2007
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6093700A | Method of inducing an immune response using vaccinia virus recombinants encoding GM-CSF | Chemistry; Metallurgy | 35 | Expired |
| US5290551A | Treatment of melanoma with a vaccine comprising irradiated autologous melanoma tumor cells conjugated to a hapten | Human Necessities | 34 | Expired |
| US6475999B1 | Method of inducing an immune response using vaccinia virus recombinants | Chemistry; Metallurgy | 27 | Expired |
| US6333028A | Method of using haptenized ovarian carcinoma tumor cells | Human Necessities | 21 | Expired |
| US6403104B1 | Hapten-conjugated mammalian cells and methods of making and using thereof | Human Necessities | 10 | Expired |
| US6248585A | Compositions for preserving haptenized tumor cells for use in vaccines | Human Necessities | 6 | Expired |
| US6458369B1 | Composition comprising tumor cells and extracts and method of using thereof | Human Necessities | 6 | Expired |
| US8435784B2 | Cryopreservation of haptenized tumor cells | Human Necessities | 5 | Active |
| US7297330B2 | Low dose haptenized tumor cell and tumor cell extract immunotherapy | Human Necessities | 1 | Expired |
| US7585512B1 | Composition and method of using tumor cells | Human Necessities | 0 | Expired |
| US7560103B2 | Composition and method of using carcinoma tumor cells | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.